UnitedHealth Group studies COVID-19 risks with sickle cell
![](https://www.hennepinhealthcare.org/wp-content/plugins/bb-plugin/img/pixel.png)
A study on potential COVID-19 risks with sickle cell trait is needed, said Dr. Douglas Rausch, division director for hematology/oncology at Hennepin Healthcare. Rausch pointed to a report from a medical journal in June that also speculated on a connection between carrying the trait and suffering serious illness from the coronavirus.